Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238535.RAjMJx2nWmZtuWUi7kKfFDcHTzHUwVgzuhxt_sK8hwERY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238535.RAjMJx2nWmZtuWUi7kKfFDcHTzHUwVgzuhxt_sK8hwERY130_assertion type Assertion NP1238535.RAjMJx2nWmZtuWUi7kKfFDcHTzHUwVgzuhxt_sK8hwERY130_head.
- NP1238535.RAjMJx2nWmZtuWUi7kKfFDcHTzHUwVgzuhxt_sK8hwERY130_assertion description "[The patient was treated with the PI(3)K? inhibitor BYL719, which achieved a lasting clinical response, but the patient eventually became resistant to this drug (emergence of lung metastases) and died shortly thereafter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238535.RAjMJx2nWmZtuWUi7kKfFDcHTzHUwVgzuhxt_sK8hwERY130_provenance.
- NP1238535.RAjMJx2nWmZtuWUi7kKfFDcHTzHUwVgzuhxt_sK8hwERY130_assertion evidence source_evidence_literature NP1238535.RAjMJx2nWmZtuWUi7kKfFDcHTzHUwVgzuhxt_sK8hwERY130_provenance.
- NP1238535.RAjMJx2nWmZtuWUi7kKfFDcHTzHUwVgzuhxt_sK8hwERY130_assertion SIO_000772 25409150 NP1238535.RAjMJx2nWmZtuWUi7kKfFDcHTzHUwVgzuhxt_sK8hwERY130_provenance.
- NP1238535.RAjMJx2nWmZtuWUi7kKfFDcHTzHUwVgzuhxt_sK8hwERY130_assertion wasDerivedFrom befree-2016 NP1238535.RAjMJx2nWmZtuWUi7kKfFDcHTzHUwVgzuhxt_sK8hwERY130_provenance.
- NP1238535.RAjMJx2nWmZtuWUi7kKfFDcHTzHUwVgzuhxt_sK8hwERY130_assertion wasGeneratedBy ECO_0000203 NP1238535.RAjMJx2nWmZtuWUi7kKfFDcHTzHUwVgzuhxt_sK8hwERY130_provenance.